GlassScriptPhysician profile
Audry Kang
NPI 1023466182
$4,008.17
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.15 · 2020: $77.49 · 2021: $111 · 2022: $1,586 · 2023: $1,776 · 2024: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,221 · Travel and Lodging: $858 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,221.05 |
| Travel and Lodging | $858.46 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,318.66 | 2021-2022 | |
| Procept Biorobotics Corporation | $551.07 | 2023 | Aquabeam Robotic System |
| Teleflex LLC | $528.66 | 2023 | Urolift |
| Boston Scientific Corporation | $239.53 | 2019-2023 | Rezum Generator |
| Abbvie INC. | $220.89 | 2022-2024 | |
| Pfizer INC. | $161.80 | 2022-2024 | |
| Astellas Pharma US INC | $129.58 | 2022-2023 | Myrbetriq |
| Urogen Pharma, INC. | $102.61 | 2022-2024 | Jelmyto |
| Tolmar, INC. | $101.98 | 2023-2024 | |
| Angiodynamics, INC. | $85.32 | 2022 | |
| Sumitomo Pharma America, INC. | $77.82 | 2023 | Gemtesa |
| Accord Healthcare, INC. | $60.59 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $60.05 | 2022-2024 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $57.06 | 2023-2024 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $55.24 | 2022-2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $48.14 | 2023 | Oxlumo |
| Olympus America INC. | $31.28 | 2023 | Olympus, Itind System |
| Myriad Genetic Laboratories, INC. | $31.03 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $30.78 | 2022 | |
| 180 Medical, INC. | $22.82 | 2023 | Cure Catheter |
| Ethicon US, LLC | $22.20 | 2024 | Echelon; Endopath |
| Merck Sharp & Dohme LLC | $18.28 | 2023 | Keytruda |
| Baxter Healthcare | $16.94 | 2024 | Perclot |
| Medtronic, INC. | $14.70 | 2023 | Signia |
| Smith+Nephew, INC. | $13.50 | 2023 | Stravix Pl |
| Travere Therapeutics, INC. | $7.64 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audry Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.